CLINICAL_TRIALS
trial_result
· 2010-06-15
Clinical Trial Update: Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities
Summary
A completed clinical trial evaluating Spiriva (tiotropium) 18 µg once daily in Chinese patients with chronic obstructive pulmonary disease across different dise…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2010-06-15